Renal Denervation Insights
Published: 12 February 2021
9m 14sPart 2 | Session 3 TCT 2019: RF renal denervation – Prof Andrew Sharp
59m 59sPart 1 | Session 1 The Future of Hypertension Management – Renal Denervation Provides Another Treatment Option Justin E Davies, Faisal Sharif, Roland E Schmieder, Flavio Ribichini, Isabella Sudano
1h 1m 3sPart 1 | Session 2 El futuro del manejo de la hipertensión: la denervación renal brinda otra opción de tratamiento Oriol Rodriguez, Maribel Troya
59m 14sPart 1 | Session 3 Die Zukunft des Hypertoniemanagements – Renale Denervierung bietet eine weitere Behandlungsoption Joachim Weil, Oliver Dörr
1h 2m 27sPart 1 | Session 4 Il futuro della gestione dell’ ipertensione - La Denervazione renale, una nuova opzione di trattamento Flavio Ribichini, Stefano Taddei
5m 47sPart 1 | Session 5 Clinical Event Reductions in High-Risk Hypertension Patients Treated with Radiofrequency Renal Denervation Roland E Schmieder
5m 3sPart 1 | Session 6 Radiofrequency Renal Denervation in a High-risk Population: The Verona experience Flavio Ribichini
6m 40sPart 1 | Session 7 Patient Profiles for Renal Denervation Isabella Sudano
30m 24sPart 2 | Session 1 The Science of Radiofrequency Renal Denervation – Part 1 Andrew SP Sharp, Stefan Tunev
Global Experts Discuss Renal Denervation as an Additional Treatment Option for Uncontrolled Hypertension
Review the evidence on radiofrequency renal denervation, including safety, efficacy and durability data and practical aspects around patient selection and management.
Medical Education Program
Patient Selection and Practical Implementation of Renal Denervation in Patients With Treatment-Resistant Hypertension
This case-based course brings together opinion leaders engaged in RDN to review the evidence, discuss trial data, and practical aspects around patient selection and management.
Click here to watch:
More from this programme
Clinical Data and Patient Identification
Science of Radiofrequency Renal Denervation
Andrew SP Sharp
Prof Andrew Sharp is a Consultant Cardiologist at the University Hospital of Wales, Cardiff, UK. Andrew qualified from Edinburgh Medical School in 1998. He was appointed as a Consultant Cardiologist at the Royal Devon and Exeter Hospital in 2011 and Honorary Associate Professor by the University of Exeter in 2018 before moving to the University Hospital of Wales in Cardiff in the summer of 2019.
Andrew conducted his early training at the Royal Infirmary of Edinburgh, before moving to London for his senior clinical training, completing the prestigious Milan-Imperial Interventional Cardiology Fellowship programme. Dr Sharp was awarded an MD postgraduate research degree from the University of Edinburgh for his work on the hypertensive heart and his current research interests include device-based treatments for hypertension, pulmonary embolism, intracoronary imaging and coronary physiology.
Andrew's specialist interests include the pharmacological and interventional…
Veterinary Pathologist, Fellow in Comparative Medicine, specializing in the field of medical device pathology